| Secondary |
| Drug Use For Unknown Indication |
14.7% |
| Rheumatoid Arthritis |
10.3% |
| Hypertension |
9.6% |
| Prophylaxis |
7.0% |
| Constipation |
6.7% |
| Gastritis |
5.4% |
| Infection |
4.1% |
| Gastric Ulcer |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Cerebral Infarction |
3.7% |
| Wound Complication |
3.7% |
| Cancer Pain |
3.6% |
| Convulsion Prophylaxis |
3.4% |
| Insomnia |
3.4% |
| Gastric Cancer |
3.0% |
| Nasopharyngitis |
2.9% |
| Pyrexia |
2.9% |
| Osteoporosis |
2.7% |
| Pain |
2.7% |
| Renal Transplant |
2.5% |
|
| Stevens-johnson Syndrome |
9.3% |
| Hepatic Function Abnormal |
7.2% |
| Interstitial Lung Disease |
7.2% |
| White Blood Cell Count Decreased |
7.2% |
| Hepatitis Fulminant |
5.2% |
| Liver Disorder |
5.2% |
| Stomatitis |
5.2% |
| Toxic Skin Eruption |
5.2% |
| Vomiting |
5.2% |
| Abdominal Pain Upper |
4.1% |
| Drug Eruption |
4.1% |
| Osteomyelitis |
4.1% |
| Overdose |
4.1% |
| Pancytopenia |
4.1% |
| Pyrexia |
4.1% |
| Sepsis |
4.1% |
| Sudden Hearing Loss |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Death |
3.1% |
| Fear |
3.1% |
|
| Concomitant |
| Rheumatoid Arthritis |
16.2% |
| Prophylaxis |
14.3% |
| Hypertension |
10.2% |
| Drug Use For Unknown Indication |
8.5% |
| Product Used For Unknown Indication |
8.1% |
| Gastritis |
6.5% |
| Constipation |
4.3% |
| Hepatitis C |
3.9% |
| Insomnia |
3.8% |
| Osteoporosis |
3.4% |
| Chronic Hepatitis C |
3.1% |
| Diabetes Mellitus |
3.0% |
| Pain |
2.5% |
| Gastric Ulcer |
2.3% |
| Gastritis Prophylaxis |
2.2% |
| Multiple Myeloma |
2.0% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Hyperlipidaemia |
1.4% |
| Cancer Pain |
1.4% |
| Herpes Zoster |
1.4% |
|
| White Blood Cell Count Decreased |
13.1% |
| Pyrexia |
8.0% |
| Rash |
8.0% |
| Interstitial Lung Disease |
7.0% |
| Vomiting |
6.9% |
| Hepatic Function Abnormal |
5.9% |
| Renal Impairment |
5.7% |
| Pneumonia |
5.6% |
| Platelet Count Decreased |
5.1% |
| Liver Disorder |
4.3% |
| Neutrophil Count Decreased |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| Rhabdomyolysis |
3.5% |
| Sepsis |
3.5% |
| Nausea |
2.9% |
| Renal Failure Acute |
2.7% |
| Decreased Appetite |
2.6% |
| Thrombocytopenia |
2.6% |
| Hypoglycaemia |
2.5% |
| Urinary Tract Infection |
2.5% |
|
| Interacting |
|
| Drug Interaction |
50.0% |
| Eczema |
50.0% |
|
